<DOC>
	<DOCNO>NCT00294294</DOCNO>
	<brief_summary>The purpose study determine whether prophylactic antipyretic treatment vaccination Prevenar concomitant hexavalent DTPa combination vaccine reduce rate febrile reaction .</brief_summary>
	<brief_title>Study Evaluating Treatment Fever Children Who Have Been Vaccinated With Prevenar Infanrix Hexa</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infant age 55 112 day Subject 's parents/legal guardian provide write informed consent Prematurely born subject &lt; 37 week gestation Known suspect disease immune system Known suspect hypersensitivity vaccine vaccine component</criteria>
	<gender>All</gender>
	<minimum_age>56 Days</minimum_age>
	<maximum_age>112 Days</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>vaccine</keyword>
	<keyword>infant</keyword>
</DOC>